Weight loss: France bankrolls EndoBarrier cost trial for GI Dynamics June 21, 2013 By Sony Salzman Leave a Comment French regulators will fund a trial looking at the cost and utility of the EndoBarrier device for Type II diabetes and weight loss made by GI Dynamics (ASX:GID).